TRADING UPDATES: Time To Act acquires MTE Heat Treatment

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Hamak Strategy Ltd - Africa-focused gold exploration firm and digital asset treasury manager - Reports "further encouraging assay results" from 11 drill holes in the 4,125 metre reverse circulation drill programme at the Akoko oxide gold project in southwest Ghana. Says the new results include 1.87 grams per tonne gold over 13.0 metres, including 3.64 g/t Au over 4.0 metres. Says 23 holes totalling 1,487 metres have been drilled to date, focused on the Akoko north area, which was previously defined as having gold mineralisation. Notes that soft ground conditions gave rise to lower recoveries in hole 2026-036, with no sample returned across part of the anticipated higher-grade mineralised zone, but says the estimated intersection of 1.06g/t gold over 45 metres generally confirms the previous results. "The results continue to validate our geological model, as interpreted from historical drill programmes, with wide, near-surface oxide gold mineralisation being intersected," says Chief Executive Officer Karl Smithson. "The consistency of intersections will assist in the confidence of the independent and industry standard mineral resource estimate and preliminary economic assessment that we plan to commission towards the end of the current drilling programme."

----------

Time To Act PLC - Stockton-On-Tees, England-based engineering company - Acquires the business and assets of MTE Heat Treatment Ltd for GBP500,000 from its administrators, RSM UK Restructuring Advisory LLP, through its newly-formed subsidiary Metal Treatment & Engineering Ltd. Notes that MTE reported turnover of GBP2.8 million for 2025, down 21% from GBP3.6 million in 2024. Says GBP3.0 million in sales, plus positive cash flow and earnings before interest, tax, depreciation and amortisation, "are realistic ambitions for the first annualised trading period". Says the acquisition is highly complementary to its existing Diffusion Alloys business, and that it sees an immediate opportunity in offering boronising as a post-heat treatment coating for gear parts and in a number of coating processes that currently use external pre- or post-coat heat treatment.

----------

Novacyt SA - biotechnology group focused on clinical diagnostics - Launches the Yourgene Insight DPYD assay, which it says uses genetic insights to facilitate safer chemotherapy treatments. Says the genotyping test, which has the same workflow and format as its original DPYD kit, can identify cancer patients with Dihydropyrimidine Dehydrogenase deficiency, which can cause severe and sometimes lethal side effects in patients being treated with the chemotherapeutic drug 5-Fluorouracil. This is commonly used to treat colorectal, head and neck, breast, pancreatic and stomach cancers. Highlights the new test's "ready-to-use reagents, simple data interpretation to identify the presence or absence of 19 variants and a fast turnaround time enabling results to be provided the same day". CEO Lyn Rees says the assay enables "a streamlined, cost-effective pharmacogenetic workflow".

----------

By Emma Curzon, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2026 Alliance News Ltd. All Rights Reserved.

Hamak Strategy